TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 DKK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
669
|
517
|
798 |
| Financial expenses |
35
|
72
|
280 |
| Earnings before taxes |
216
|
-75
|
62 |
| EBITDA |
248
|
-11
|
342 |
| Total assets |
9,692
|
9,555
|
9,503 |
| Current assets |
493
|
503
|
734 |
| Current liabilities |
101
|
168
|
246 |
| Equity capital |
9,550
|
9,343
|
9,187 |
| - share capital |
67
|
66
|
63 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
98.5%
|
97.8%
|
96.7% |
| Turnover per employee |
669
|
517
|
798 |
| Profit as a percentage of turnover |
32.3%
|
-14.5%
|
7.8% |
| Return on assets (ROA) |
2.6%
|
0.0%
|
3.6% |
| Current ratio |
488.1%
|
299.4%
|
298.4% |
| Return on equity (ROE) |
2.3%
|
-0.8%
|
0.7% |
| Change turnover |
142
|
-313
|
306 |
| Change turnover % |
27%
|
-38%
|
62% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.